Picture of Chordate Medical Holding AB (publ) logo

CMH — Chordate Medical Holding AB (publ) News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: Chordate Medical Holding Resumes Finnish Study Of Chronical Migraine

Feb 23 (Reuters) - Chordate Medical Holding publ AB
 CMHM.NGM :
    * RESUMES FINNISH STUDY OF CHRONICAL MIGRAINE
    * STUDY, WHICH IS BEING CARRIED OUT AT NINE CLINICS IN
GERMANY AND
FINLAND, WAS SUSPENDED DUE TO THE COVID-19 PANDEMIC IN 2020
    * THE ENTIRE STUDY IS EXPECTED TO BE COMPLETED AS PREVIOUSLY
COMMUNICATED BY THE SUMMER OF 2021

Source text for Eikon:  ID:nBQN68d6bL 
Further company coverage:  CMHM.NGM 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))

Recent news on Chordate Medical Holding AB (publ)

See all news